SCHEMBL5828593

SCHEMBL5828593

COc1cc2c(N=C(NCCCN(C)C)Nc3c(C)cccc3C)ncnc2cc1O

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RET P07949 7/20 0.41
KIF5B P33176 5/20 0.41
EGFR P00533 4/20 0.39
FYN P06241 1/20 0.37
AURKB Q96GD4 2/20 0.36
KDR P35968 6/20 0.36
AURKA O14965 1/20 0.36
RAF1 P04049 2/20 0.35
BRAF P15056 2/20 0.35
PRMT1 Q99873 1/20 0.35
FGFR1 P11362 1/20 0.35
FLT1 P17948 1/20 0.35
CDK2 P24941 1/20 0.35
PIK3R1 P27986 1/20 0.35
EPHB2 P29323 1/20 0.35
TTBK1 Q5TCY1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5828583 1.00 RET (0.41) RETKIF5BEGFRFYNAURKB
SCHEMBL5828492 0.95 RET (0.41) RETKIF5BEGFRFYNAURKB
SCHEMBL5828499 0.95 RET (0.41) RETKIF5BEGFRFYNAURKB
SCHEMBL6986020 0.84 EGFR (0.46) RETKIF5BEGFRAURKBKDR
SCHEMBL5827653 0.83 PDE10A (0.47) EGFRKDRRAF1BRAF
SCHEMBL5827652 0.83 PDE10A (0.47) EGFRKDRRAF1BRAF
SCHEMBL6981093 0.79 EGFR (0.47) RETKIF5BEGFRAURKBKDR
SCHEMBL5827881 0.78 RET (0.47) RETKIF5BEGFRAURKBKDR
SCHEMBL5827885 0.78 RET (0.47) RETKIF5BEGFRAURKBKDR
SCHEMBL5829043 0.76 EPHA2 (0.52) KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7001904-B1 Guanidine derivatives quinazoline and quinoline for use in the treatment of autoimmune diseases ASTRAZENECA AB (SE) 2006-02-21 US disclosed
EP-1296973-A1 GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES AstraZeneca AB (SE) 2003-04-02 EP disclosed
WO-2002000644-A1 GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES ASTRAZENECA AB (SE) 2002-01-03 WO disclosed